Related Experiment Video

Updated: Jul 14, 2025

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells
09:41

An Organotypic High Throughput System for Characterization of Drug Sensitivity of Primary Multiple Myeloma Cells

Published on: July 15, 2015

8.7K

SpaRx: elucidate single-cell spatial heterogeneity of drug responses for personalized treatment

Ziyang Tang1, Xiang Liu2, Zuotian Li2,3

  • 1Department of Computer and Information Technology, Purdue University, Indiana, USA.

Briefings in Bioinformatics
|October 5, 2023
PubMed

Insights

Spatial heterogeneity in tumors causes varied drug responses. SpaRx, a new model, analyzes single-cell spatial transcriptomics to map cellular drug resistance and identify personalized treatment strategies.

Area of Science:

  • Genomics
  • Computational Biology
  • Cancer Research

Background:

  • Tumor cell heterogeneity influences drug response and resistance.
  • Spatial transcriptomics technologies (CosMx, MERSCOPE, Xenium) offer single-cell resolution of gene expression.
  • Understanding spatial drug response is crucial for personalized cancer therapy.

Purpose of the Study:

  • To develop a computational model, SpaRx, for analyzing spatial cellular heterogeneity in drug response.
  • To integrate pharmacogenomic data with spatial transcriptomics for predicting drug sensitivity.
  • To identify mechanisms of spatial drug resistance within tumor microenvironments.

Main Methods:

  • Developed SpaRx, a graph-based domain adaptation model.
  • Employed hybrid learning with dynamic adversarial adaptation.
  • Benchmarked SpaRx performance against various data conditions (dropout, noise, coverage).

Main Results:

  • SpaRx demonstrated robust and superior performance in analyzing spatial transcriptomics data.
  • Identified heterogeneous drug sensitivity and resistance in tumor cells across different spatial locations.
  • Revealed that resistant tumor cells form localized ecosystems with surrounding cells.

Conclusions:

  • SpaRx effectively characterizes spatial therapeutic variability and uncovers mechanisms of drug resistance.
  • The model facilitates the identification of personalized drug targets and combination therapies.
  • This approach enhances the understanding of tumor biology and treatment optimization.
Keywords:
adversarial learninggraph transformersingle-cell spatial transcriptomicsspatial cellular drug response

More Related Videos

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation10:24

Generation of Heterogeneous Drug Gradients Across Cancer Populations on a Microfluidic Evolution Accelerator for Real-Time Observation

Published on: September 19, 2019

6.4K
An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects07:37

An Integrated Raman Spectroscopy and Mass Spectrometry Platform to Study Single-Cell Drug Uptake, Metabolism, and Effects

Published on: January 9, 2020

9.5K

Related Concept Videos

Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
4.9K
Analysis of Population Pharmacokinetic Data01:12

Analysis of Population Pharmacokinetic Data

Analysis of population pharmacokinetic data involves studying the behavior of drugs within diverse populations to understand their pharmacokinetic parameters. Traditional pharmacokinetic methods typically involve collecting samples from a few individuals and estimating these parameters. While these methods are commonly used, they have limitations in capturing the variability in drug response among individuals or heterogeneous populations. Population pharmacokinetics is employed to address these...
273
Factors Affecting Drug Response: Overview01:21

Factors Affecting Drug Response: Overview

When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.0K